APP and Alzheimer disease: The 30 days course of oral administration of a semipurified extract of Withania somnifera was reported to inhibit the aggregation of Aβ proteins in the brains of middle-aged and old APP/PS1 Alzheimer’s disease transgenic mice through enhanced clearance of the protein [341].